Tian‐Run Lv
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cholangiocarcinoma and Gallbladder Cancer Studies
Papers in
- Surgery 27
- Cholangiocarcinoma and Gallbladder Cancer Studies 27
-
- Gallbladder and Bile Duct Disorders 5
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Hai‐Jie Hu (32 shared papers)Fu‐Yu Li (29 shared papers)Rui-Qi Zou (9 shared papers)Siqi Yang (4 shared papers)Jun Yu (1 shared paper)Heng‐Chung Kung (1 shared paper)Tiantian Wang (1 shared paper)Yanwen Jin (18 shared papers)
- Journals
- European Journal of Surgical Oncology (4 papers)Frontiers in Oncology (3 papers)Cancer Medicine (3 papers)Current Problems in Surgery (2 papers)International Journal of Surgery (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Tian‐Run Lv
34 papers receiving 355 citations
Tian‐Run Lv's Hit Papers
Peers
Comparison fields: 5 of 68
- Hepatology 30
- Surgery 133
- Cancer Research 39
- Oncology 68
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Tian‐Run Lv
This map shows the geographic impact of Tian‐Run Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Run Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Run Lv more than expected).
Fields of papers citing papers by Tian‐Run Lv
This network shows the impact of papers produced by Tian‐Run Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Run Lv. The network helps show where Tian‐Run Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Tian‐Run Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Organoids: The current status and biomedical applications Hit paper breakdown → | 2023 | 163 |
| 2 | 2024 | 30 | |
| 3 | 2021 | 20 | |
| 4 | 2021 | 12 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 8 | |
| 8 | 2021 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2024 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 4 |
About Tian‐Run Lv
Tian‐Run Lv is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Hepatology, Oncology and Epidemiology, having authored 36 papers that have together received 357 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers), Gallbladder and Bile Duct Disorders (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Neuroendocrine Tumor Research Advances (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (30 citations), Surgery (133 citations), Cancer Research (39 citations), Oncology (68 citations) and Pulmonary and Respiratory Medicine (45 citations). Tian‐Run Lv has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Hai‐Jie Hu, Fu‐Yu Li, Rui-Qi Zou, Siqi Yang, Jun Yu, Heng‐Chung Kung, Tiantian Wang, Yanwen Jin, Wenjie Ma and Fei Liu. Their work appears in journals such as European Journal of Surgical Oncology, Frontiers in Oncology, Cancer Medicine, Current Problems in Surgery and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.